 | |
| Clinical data | |
|---|---|
| Other names | Δ7-Estrone; 7-Dehydroestrone; Estra-1,3,5(10),7-tetraen-3-ol-17-one |
| Routes of administration | By mouth |
| Drug class | Estrogen |
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.006.809 |
| Chemical and physical data | |
| Formula | C18H20O2 |
| Molar mass | 268.356 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Equilin is anaturally occurringestrogensex hormone found inhorses as well as amedication.[1][2][3] It is one of the estrogens present in the estrogencombination drug preparations known asconjugated estrogens (CEEs; e.g.Premarin) andesterified estrogens (EEs; e.g.Estratab,Menest).[2][3] CEEs is the most commonly used form of estrogen medications inhormone replacement therapy (HRT) formenopausal symptoms in theUnited States.[3]Estrone sulfate is the major estrogen in CEEs (about 50%) while equilin sulfate is the second major estrogen in the formulation, present as about 25% of the total.[2][3]
Equilin is an estrogen, or anagonist of theestrogen receptors (ERs), theERα andERβ.[2] In terms ofrelative binding affinity for the ERs, equilin has about 13% and 49% of that of estradiol for the ERα and ERβ, respectively.[2] Analogously to the reversible transformation ofestrone intoestradiol by17β-hydroxysteroid dehydrogenase, equilin can be converted into the more potent estrogen17β-dihydroequilin in the body.[2][3] This estrogen has about 113% and 108% of the relative binding affinities of estradiol for the ERα and ERβ, respectively.[2][3] Equilin is present in CEEs in the form of equilin sulfate, which itself is inactive and acts as aprodrug of equilin viasteroid sulfatase.[2][3]
Similarly tosynthetic estrogens likeethinylestradiol, equilin and CEEs have disproportionate effects in certaintissues such as theliver anduterus relative tobioidentical human estrogens like estradiol and estrone.[2] Because of their disproportionate potency in the liver, equilin and CEEs have relatively increased effects onliver protein synthesis compared to estradiol.[2]
A dosage of 0.25 mg/day equilin sulfate is equivalent to 0.625 mg/day CEEs in terms of relief fromhot flashes.[2] At a dosage of 0.625 mg/day equilin sulfate, the increases in circulating levels ofsex hormone-binding globulin (SHBG),corticosteroid-binding globulin, andangiotensinogen were 1.5 to 8 times those observed withestrone sulfate.[2] Equilin has about 42% of the relative potency of CEEs in thevagina and 80% of the relative potency of CEEs in theuterus, while its more active form, 17β-dihydroequilin, has about 83% of the relative potency of CEEs in the vagina and 200% of the relative potency of CEEs in the uterus.[2]
| Estrogen | HFTooltip Hot flashes | VETooltip Vaginal epithelium | UCaTooltip Urinary calcium | FSHTooltip Follicle-stimulating hormone | LHTooltip Luteinizing hormone | HDLTooltip High-density lipoprotein-CTooltip Cholesterol | SHBGTooltip Sex hormone-binding globulin | CBGTooltip Corticosteroid-binding globulin | AGTTooltip Angiotensinogen | Liver |
|---|---|---|---|---|---|---|---|---|---|---|
| Estradiol | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
| Estrone | ? | ? | ? | 0.3 | 0.3 | ? | ? | ? | ? | ? |
| Estriol | 0.3 | 0.3 | 0.1 | 0.3 | 0.3 | 0.2 | ? | ? | ? | 0.67 |
| Estrone sulfate | ? | 0.9 | 0.9 | 0.8–0.9 | 0.9 | 0.5 | 0.9 | 0.5–0.7 | 1.4–1.5 | 0.56–1.7 |
| Conjugated estrogens | 1.2 | 1.5 | 2.0 | 1.1–1.3 | 1.0 | 1.5 | 3.0–3.2 | 1.3–1.5 | 5.0 | 1.3–4.5 |
| Equilin sulfate | ? | ? | 1.0 | ? | ? | 6.0 | 7.5 | 6.0 | 7.5 | ? |
| Ethinylestradiol | 120 | 150 | 400 | 60–150 | 100 | 400 | 500–600 | 500–600 | 350 | 2.9–5.0 |
| Diethylstilbestrol | ? | ? | ? | 2.9–3.4 | ? | ? | 26–28 | 25–37 | 20 | 5.7–7.5 |
Sources and footnotes Notes: Values are ratios, with estradiol as standard (i.e., 1.0).Abbreviations:HF = Clinical relief ofhot flashes.VE = Increasedproliferation ofvaginal epithelium.UCa = Decrease inUCaTooltip urinary calcium.FSH = Suppression ofFSHTooltip follicle-stimulating hormone levels.LH = Suppression ofLHTooltip luteinizing hormone levels.HDL-C,SHBG,CBG, andAGT = Increase in the serum levels of theseliver proteins. Liver = Ratio of liver estrogenic effects to general/systemic estrogenic effects (hot flashes/gonadotropins).Sources: See template. | ||||||||||
Equilin has about 8% of therelative binding affinity oftestosterone for SHBG, relative to 12% in the case ofestrone.[2] In terms ofplasma protein binding, it is bound 26% to SHBG and 13% toalbumin.[2] Themetabolic clearance rates of equilin and equilin sulfate are 2,640 L/day/m2 and 175 L/day/m2, respectively.[2] In accordance, thebiological half-life of equilin sulfate is substantially longer than that of equilin.[2] Equilin is converted into17β-dihydroequilin in theliver and in othertissues.[2][3] Equilin and 17β-dihydroequilin can also be transformed intoequilenin and17β-dihydroequilenin.[2][3] Equilin isexcreted in the form ofglucuronide conjugates.[2]
Equilin, also known as δ7-estrone or as 7-dehydroestrone, as well as estra-1,3,5(10),7-tetraen-3-ol-17-one, is anaturally occurringestranesteroid and ananalogue ofestrone.[2][3] In terms ofchemical structure andpharmacology, equilin is to17β-dihydroequilin (δ7-17β-estradiol) as estrone is toestradiol.[2][3]
